ArticleJournal of hand surgery global online2026
Enhancing Hand Vascular Assessment: The Role of Hyperspectral Imaging in Perfusion Monitoring.
Article in Journal of hand surgery global online, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High-to-Low Spectral Mapping for Cross-System Feature Adaptation in Medical Hyperspectral Imaging.Bioengineering (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Accurate assessment and monitoring of tissue perfusion are critical in diagnosing and managing vascular diseases of the hand. Traditional methods, including clinical examination, pulse oximetry, and Doppler ultrasound, have limitations in detecting early or subtle perfusion deficits. Hyperspectral imaging (HSI) is a noninvasive, real-time technology that generates quantitative perfusion maps by measuring oxygen saturation, oxyhemoglobin, and deoxyhemoglobin levels. To the best of our knowledge, this is the first study of its kind to evaluate the clinical use of HSI in assessing perfusion abnormalities in vascular conditions of the hand and its emerging applications in hand surgery. Methods: A single center study was conducted from 2021 to 2025, involving 5 patients with various upper-extremity vascular conditions, each followed to early 2025. Perfusion images were obtained using the HyperView (HyperMed, Memphis, TN) system before and after surgical or procedural interventions. Results were compared against the contralateral hand or historical normal values from the prior-generation HyperView (OxyVu-1) system. Results: Hyperspectral imaging effectively identified perfusion deficits, guided urgent clinical decision-making, and monitored postoperative improvements. In one case, HSI demonstrated a 5% increase in tissue oxygen saturation after ulnar artery reconstruction, correlating with successful wound healing. Another patient with Raynaud's phenomenon showed a 23% perfusion increase following botulinum toxin injection. Hyperspectral imaging also detected thrombosis and monitored perioperative oxygen saturation changes in real-time. Conclusions: Hyperspectral imaging offers a novel, objective approach to perfusion assessment in hand and upper-extremity vascular disease, addressing key limitations of traditional methods. Its integration into clinical workflows holds promise for enhancing real-time, data-driven decision-making in hand surgery and vascular medicine. Type of Study/level of evidence: Diagnostic IV.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.